We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
15.50 | 0.98% | 1,599.00 | 1,599.50 | 1,600.50 | 1,600.00 | 1,575.00 | 1,579.50 | 5,149,016 | 16:35:14 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.37 | 65.87B |
TIDMGSK
RNS Number : 6530N
GlaxoSmithKline PLC
10 August 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================== a) Name Mrs V A Whyte ==== ====================================== ================================================== b) Position/status SVP & Company Secretary ==== ====================================== ================================================== c) Initial notification/ Initial Notification amendment ==== ====================================== ================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================== a) Name GlaxoSmithKline plc ==== ====================================== ================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================== b) Nature of the The receipt of 4,360 Ordinary Shares from transaction spouse for nil consideration. ==== ====================================== ================================================== c) Price(s) and volume(s) Price(s) Volume(s) ==== ====================================== ======================= ====================== GBP0.00 4,360 =================================================================== ====================== d) Aggregated information n/a (single transaction) ==== Aggregated volume Price ================================================================ ============================= e) Date of the transaction 2017-08-09 ==== ====================================== ================================================== f) Place of the transaction n/a ==== ====================================== ================================================== Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Mr I W Whyte ==== ====================================== ==================================================== b) Position/status PCA of Mrs V A Whyte (SVP & Company Secretary) ==== ====================================== ==================================================== c) Initial notification/ Initial Notification amendment ==== ====================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ====================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ==================================================== b) Nature of the Transfer of 4,360 Ordinary Shares to spouse transaction for nil consideration. ==== ====================================== ==================================================== c) Price(s) and volume(s) Price(s) Volume(s) ==== ====================================== ======================== ======================= GBP0.00 4,360 ==================================================================== ======================= d) Aggregated information n/a (single transaction) ==== Aggregated volume Price ================================================================= ============================== e) Date of the transaction 2017-08-09 ==== ====================================== ==================================================== f) Place of the transaction n/a ==== ====================================== ====================================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHKBLBFDVFZBBV
(END) Dow Jones Newswires
August 10, 2017 05:50 ET (09:50 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions